Adjuvant treatment for early epithelial ovarian cancer: Results of two randomised clinical trials comparing cisplatin to no further treatment or chromic phosphate (32P)

Annals of Oncology

Volumn 6, Issue 9, 1995, Pages 887-893

  Bolis, G ^b   Colombo, N ^c   Pecorelli, S ^d   Torri, V ^a   Marsoni, S ^a   Bonazzi, C ^c   Chiari, S ^c   Favalli, G ^d   Mangili, G ^e   Presti, M ^g   Zanaboni, F ^f   Mangioni, C ^c  

^a Department of Oncology   (Italy)

^b Clinica Mangiagalli   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d Clinica Ostetrico Ginecologica   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f OSPEDALE DI CIRCOLO   (Italy)

^g Ospedale di Voghera   (Italy)

Author keywords

Chemotherapy; Early ovarian neoplasm; Randomised trial

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHROMIUM PHOSPHATE P 32; CISPLATIN; DEXAMETHASONE; METOCLOPRAMIDE; PHOSPHORUS 32;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OVARY CARCINOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CHROMIUM COMPOUNDS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHOSPHATES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0028862816     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a059355     Document Type: Article

References (0)